The candidate Ad5-nCoV, which goes by the trade name Convidecia, uses a harmless common cold virus to carry genetic information of coronavirus’ protein to elicit immune responses, has already begun Phase III trials in Pakistan, Russia and Mexico.
The 50-case milestone could be hit faster than previously expected judging from how the virus is spreading, Zhu told an industry event, without specifying when the analysis would start. China has five home-grown candidates currently undergoing Phase III trials. None have so far produced interim results.
Effective vaccines take years to develop for safety efficacy. Rush to market vaccines have caution warning light flashing but corporate greed and stupid politicians will have millions upon millions vaccinated without any long term health consequences, only dream land.
Kala ko about CJ hahahah tulog na raw ako kbye
Great but this time ask them to share full data about vaccine test results, including people injured or worse please
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.